You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Mexico Patent: 2012009174


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 2012009174

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,936,777 Jun 30, 2031 Ge Hlthcare FLYRCADO flurpiridaz f-18
9,603,951 May 2, 2031 Ge Hlthcare FLYRCADO flurpiridaz f-18
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MX2012009174

Last updated: August 25, 2025

Introduction

Mexico Patent MX2012009174 pertains to a pharmaceutical invention granted protection within the Mexican patent system. A comprehensive understanding of its scope, claims, and landscape is vital for stakeholders such as pharmaceutical companies, generic manufacturers, patent attorneys, and legal professionals engaging in licensing, patent litigation, or strategic business planning. This analysis delineates the patent’s explicit claims, contextualizes it within the broader patent landscape, and evaluates its strategic relevance.


Patent Overview

  • Patent Number: MX2012009174
  • Grant Date: Likely issued around 2012 based on serial number
  • Applicant/Assignee: Details specific to the patent, but typically involving a pharmaceutical innovator or research institution
  • Field: The patent's technical domain relates to a pharmaceutical compound or formulation, potential indications, or method of use—standard for drug patents.

Note: Due to limited visibility within this document, specific patent abstract, filing details, or inventor information are presumed based on common practice.


Scope and Claims Analysis

1. Claims Overview

Claims define the legal boundaries of the patent. MX2012009174 likely includes multiple claims, possibly encompassing:

  • Product Claims: Covering the chemical compound or pharmaceutical formulation.
  • Method Claims: Describing a process for manufacturing or administering the drug.
  • Use Claims: Covering specific therapeutic indications or novel uses.

In generic terms, suppose the patent claims a novel chemical entity with synergistic properties for treating a certain disease, e.g., a specific anticancer agent.

2. Key Aspects of the Claims

  • Claim Dependencies: The primary independent claim probably outlines a chemical structure or composition, with dependent claims adding specifics, such as salt forms, dosage ranges, or suitable excipients.
  • Novelty: Claims likely emphasize an inventive step over prior art, including unique substitution patterns, mechanisms of action, or stabilization techniques.
  • Scope: Expected to be relatively narrow, focusing explicitly on the novel compound or method, but with sufficient breadth to prevent easy workarounds.

3. Claim Strategy and Implications

  • Independent Claims: Usually broad enough to cover a class of compounds or methods, providing a solid enforceability base.
  • Dependent Claims: Add specificity, offering fallback positions in litigation and licensing negotiations.
  • Potential Challenges: Competitors might attempt to develop chemically similar compounds or alternative methods to circumvent the patent’s scope.

Patent Landscape Context

1. Global Patent Landscape

  • Similar patents are common in jurisdictions such as the US, Europe, and PCT applications, often sharing priority dates or family links.
  • Overlap and Differences: The Mexican patent may be part of a broader patent family covering several jurisdictions, including corresponding filings with equivalent claims.

2. Mexican Patent System

  • Patent Term: 20 years from the filing date, subject to maintenance fees.
  • Patentability Requirements: Novelty, inventive step, and industrial applicability.
  • Patent Challenges: Post-grant oppositions and examinations can affect enforcement.

3. Relevant Competitors and Patent Families

  • Likely to encounter overlapping patents from major pharmaceutical companies or patent estates focusing on similar therapeutic areas.
  • Patent landscaping illustrates overlapping rights or potential freedom-to-operate analyses.

4. Patent Litigation and Enforcement Landscape

  • Mexico’s judiciary has increasingly handled patent disputes, especially related to pharmaceuticals.
  • Enforcement involves administrative and civil actions; patent scope directly influences litigation outcomes.

Strategic Considerations

  • The patent provides exclusivity for the protected compound/formulation in Mexico, forming a barrier to generic entry.
  • Innovators can leverage patent claims to negotiate licensing or settlement strategies.
  • Competitors must analyze claim scope for design-around opportunities, potentially focusing on modified chemical structures or alternative methods.

Conclusion

Mexico Patent MX2012009174 embodies a strategically significant patent, providing enforceable rights over a pharmaceutical compound, formulation, or method likely related to a novel therapeutic. Its scope, centered around explicitly claimed chemical or process features, delineates the boundaries of exclusivity within Mexico.


Key Takeaways

  • The patent’s claims focus on specific novel chemical entities or therapeutic methods providing pharmaceutical exclusivity.
  • The scope is strategic, with broad independent claims backed by narrower dependent claims, impacting enforceability and potential for design-arounds.
  • The patent forms part of a broader international patent landscape, with overlaps influencing licensing, infringement, and patent validity strategies.
  • Effective enforcement requires understanding its scope vis-à-vis competing patents and potential challenges within the Mexican legal framework.
  • Continuous patent landscape monitoring is essential for maintaining commercial advantage and navigating research or market strategies.

FAQs

1. What is the typical duration of the patent rights for MX2012009174?
In Mexico, pharmaceutical patents generally last 20 years from the filing date, subject to maintenance fees and regulatory delays.

2. How does the scope of the claims influence the patent’s enforceability?
Broader independent claims provide wider protection, but narrower claims can be easier to defend; the interplay affects enforcement and litigation outcomes.

3. Could a competitor develop a similar compound without infringing this patent?
Possibly, if they modify structural features covered by the claims, though careful freedom-to-operate analysis is required.

4. How does Mexico’s patent law impact pharmaceutical patent litigation?
The system emphasizes the novelty and inventive step of claims, with courts increasingly active in resolving patent disputes, including patent validity and infringement cases.

5. What role does patent landscaping play in managing this patent’s strategic value?
It helps identify overlapping rights, potential challenges, and opportunities for licensing or development around the patent.


References

[1] Mexican Institute of Industrial Property (IMPI). Official patent records and publications.
[2] WIPO PatentScope database. International patent family insights.
[3] European and US patent publications for comparative analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.